Rosmantuzumab
CAS No. 1684393-04-1
Rosmantuzumab( —— )
Catalog No. M37100 CAS No. 1684393-04-1
Rosmantuzumab (OMP-131R10) is a humanized monoclonal antibody against R-spondin 3 (RSPO3).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 347 | Get Quote |
|
| 5MG | 560 | Get Quote |
|
| 10MG | 911 | Get Quote |
|
| 25MG | 1306 | Get Quote |
|
| 50MG | 1766 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRosmantuzumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionRosmantuzumab (OMP-131R10) is a humanized monoclonal antibody against R-spondin 3 (RSPO3).
-
DescriptionRosmantuzumab (OMP-131R10) is an anti-R-spondin 3 (RSPO3) humanized monoclonal antibody. Rosmantuzumab can be used for the research of advanced telapsed and refractory solid tumors.
-
In Vitro——
-
In VivoAnimal Model:Male C57B1/6J CCl4 liver fibrosis mouse models Dosage:25 mg/kg Administration:Intraperitoneal injection; 25 mg/kg, once a week for 4 weeks Result:Significantly decreased collagen I and collagen III mRNAs, and inhibits β-catenin cytoplasmic and nuclear translocation.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1684393-04-1
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang M, et al. Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs. PLoS One. 2020 Mar 11;15(3):e0229445.?
molnova catalog
related products
-
LW6
LW6 is a novel HIF-1 inhibitor.
-
Vaccarin E
Vaccarin E is a natural product of Vaccaria, Caryophyllaceae. Vaccarin E can be used as a reference standard.
-
ADHP
ADHP is a fluorogenic peroxidase substrate (λex=530 nm, λem=590 nm).
Cart
sales@molnova.com